- Home
- PLUG vs AGIO Comparison
PLUG vs AGIO Comparison
Compare PLUG & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- AGIO
- Stock Information
- Founded
- PLUG 1997
- AGIO 2007
- Country
- PLUG United States
- AGIO United States
- Employees
- PLUG N/A
- AGIO N/A
- Industry
- PLUG Industrial Machinery/Components
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- AGIO Health Care
- Exchange
- PLUG Nasdaq
- AGIO Nasdaq
- Market Cap
- PLUG 1.8B
- AGIO 2.0B
- IPO Year
- PLUG 1999
- AGIO 2013
- Fundamental
- Price
- PLUG $2.44
- AGIO $32.42
- Analyst Decision
- PLUG Hold
- AGIO Buy
- Analyst Count
- PLUG 21
- AGIO 7
- Target Price
- PLUG $3.85
- AGIO $56.33
- AVG Volume (30 Days)
- PLUG 69.6M
- AGIO 1.0M
- Earning Date
- PLUG 02-28-2025
- AGIO 02-13-2025
- Dividend Yield
- PLUG N/A
- AGIO N/A
- EPS Growth
- PLUG N/A
- AGIO N/A
- EPS
- PLUG N/A
- AGIO 11.80
- Revenue
- PLUG $659,505,000.00
- AGIO $32,871,000.00
- Revenue This Year
- PLUG N/A
- AGIO $33.41
- Revenue Next Year
- PLUG $27.18
- AGIO $172.14
- P/E Ratio
- PLUG N/A
- AGIO $2.75
- Revenue Growth
- PLUG N/A
- AGIO 36.79
- 52 Week Low
- PLUG $1.60
- AGIO $20.96
- 52 Week High
- PLUG $5.14
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- PLUG 47.83
- AGIO 33.53
- Support Level
- PLUG $2.55
- AGIO $32.85
- Resistance Level
- PLUG $2.97
- AGIO $35.03
- Average True Range (ATR)
- PLUG 0.32
- AGIO 1.75
- MACD
- PLUG -0.02
- AGIO 0.48
- Stochastic Oscillator
- PLUG 26.67
- AGIO 22.40
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem-from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.